MoneyWorks4Me

Abbott India informs about change in management

23 Jul 2024 Evaluate
In compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), Abbott India has informed that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors have approved the designation and remuneration of Anuj Mehra, Associate Director - GenNext as Senior Management Personnel of the Company effective August 1, 2024. He will be part of the Senior Management team of the Company. The additional details required under the SEBI Listing Regulations read with SEBI Circular Nos. CIR/CFD/CMD/412015 dated September 9, 2015 is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..